ÂÜÀòÂÒÂ×

Michael Morneau is currently the VP Finance & Administration at Viking Therapeutics. Prior to this, they were the Director of Finance at SGX Pharmaceuticals from January 2006 to December 2009. Before that, they were the Controller at Momenta Pharmaceuticals from January 2004 to December 2006. In 2009, they became the VP of Finance at Trius Therapeutics and held that title until May 2014. Prior to their work at Trius Therapeutics, they were the Controller at Gensym Corporation from January 2002 to December 2004. Before that, they worked at PwC from January 1992 to December 2001 as the Manager of Business Assurance.

Michael Morneau has a Bachelor of Arts in Mathematics from the University of New Hampshire and a Master of Science in Accounting and Business from Southern New Hampshire University.

Their manager is Brian Lian, President & CEO. They work with Amy Broidrick - SVP Corporate Development , Greg Zante - VP Finance & Operations , and Marianne Mancini - SVP Clinical Operations.